Journal Menu
► ▼ Journal Menu-
- Vaccines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
14 February 2026
Vaccines | Editor’s Choice Papers in 2024 (I)
1. “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy”
by Andrea Ceccarelli, Federica Tamarri, Raffaella Angelini, Elizabeth Bakken, Ilaria Concari, Elsa Giannoccaro, Giada Domeniconi, Michela Morri, Chiara Reali, Francesca Righi et al.
Vaccines 2024, 12(1), 51; https://doi.org/10.3390/vaccines12010051
Available online: https://www.mdpi.com/2076-393X/12/1/51
2. “Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer”
by Dechen Wangmo, Travis J. Gates, Xianda Zhao, Ruping Sun and Subbaya Subramanian
Vaccines 2024, 12(1), 63; https://doi.org/10.3390/vaccines12010063
Available online: https://www.mdpi.com/2076-393X/12/1/63
3. “DNA Vaccines: Their Formulations, Engineering and Delivery”
by Michael Kozak and Jiafen Hu
Vaccines 2024, 12(1), 71; https://doi.org/10.3390/vaccines12010071
Available online: https://www.mdpi.com/2076-393X/12/1/71
4. “Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022”
by Kimberly H. Nguyen, Yingjun Bao, Julie Mortazavi, Jennifer D. Allen, Patricia O. Chocano-Bedoya and Laura Corlin
Vaccines 2024, 12(1), 99; https://doi.org/10.3390/vaccines12010099
Available online: https://www.mdpi.com/2076-393X/12/1/99
5. “Progress and Challenges in Measles and Rubella Elimination in the WHO European Region”
by Mark Muscat, Myriam Ben Mamou, Catharina Reynen-de Kat, Dragan Jankovic, José Hagan, Simarjit Singh and Siddhartha Sankar Datta
Vaccines 2024, 12(6), 696; https://doi.org/10.3390/vaccines12060696
Available online: https://www.mdpi.com/2076-393X/12/6/696
6. “SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma”
by Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, Undine Proschmann, Tjalf Ziemssen and Katja Akgün
Vaccines 2024, 12(6), 684; https://doi.org/10.3390/vaccines12060684
Available online: https://www.mdpi.com/2076-393X/12/6/684
7. “Human Tick-Borne Diseases and Advances in Anti-Tick Vaccine Approaches: A Comprehensive Review”
by Marie-Edith Nepveu-Traversy, Hugues Fausther-Bovendo and George (Giorgi) Babuadze
Vaccines 2024, 12(2), 141; https://doi.org/10.3390/vaccines12020141
Available online: https://www.mdpi.com/2076-393X/12/2/141
8. “Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers”
by Enrique Álvarez, Michela Falqui, Laura Sin, Joseph Patrick McGrail, Beatriz Perdiguero,
Rocío Coloma, Laura Marcos-Villar, Céline Tárrega, Mariano Esteban, Carmen Elena Gómez et al.
Vaccines 2024, 12(2), 153; https://doi.org/10.3390/vaccines12020153
Available online: https://www.mdpi.com/2076-393X/12/2/153
9. “Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis”
by Milena Adina Man, Daniela Rosca, Felix Bratosin, Ovidiu Fira-Mladinescu, Adrian Cosmin Ilie, Sonia-Roxana Burtic, Ariadna Petronela Fildan, Camelia Melania Fizedean, Adelina Maria Jianu, Rodica Anamaria Negrean et al.
Vaccines 2024, 12(2), 189; https://doi.org/10.3390/vaccines12020189
Available online: https://www.mdpi.com/2076-393X/12/2/189
10. “Vaccine Strategies to Elicit Mucosal Immunity”
by Yufeng Song, Frances Mehl and Steven L. Zeichner
Vaccines 2024, 12(2), 191; https://doi.org/10.3390/vaccines12020191
Available online: https://www.mdpi.com/2076-393X/12/2/191
11. “Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination”
by Minako Yamaoka-Tojo and Taiki Tojo
Vaccines 2024, 12(3), 252; https://doi.org/10.3390/vaccines12030252
Available online: https://www.mdpi.com/2076-393X/12/3/252
12. “Barriers to and Facilitators for Accessing HPV Vaccination in Migrant and Refugee Populations: A Systematic Review”
by Davide Graci, Nicolò Piazza, Salvatore Ardagna, Alessandra Casuccio, Anton Drobov, Federica Geraci, Angelo Immordino, Alessandra Pirrello, Vincenzo Restivo, Riccardo Rumbo et al.
Vaccines 2024, 12(3), 256; https://doi.org/10.3390/vaccines12030256
Available online: https://www.mdpi.com/2076-393X/12/3/256
13. “Prolonged SARS-CoV-2 T Cell Responses in a Vaccinated COVID-19-Naive Population”
by Vassiliki C. Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, Irene V. Vasileiou, Alexandros D. Konstantinidis, Natalia I. Spyrou and Athanasios Tsakris
Vaccines 2024, 12(3), 270; https://doi.org/10.3390/vaccines12030270
Available online: https://www.mdpi.com/2076-393X/12/3/270
14. “Recent Scientific Advancements towards a Vaccine against Group A Streptococcus”
by Jingyi Fan, Istvan Toth and Rachel J. Stephenson
Vaccines 2024, 12(3), 272; https://doi.org/10.3390/vaccines12030272
Available online: https://www.mdpi.com/2076-393X/12/3/272
15. “Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines”
by Yang Xu, Kazuya Masuda, Christine Groso, Rick Hassan, Ziyou Zhou, Kelsey Broderick, Moriya Tsuji and Christopher Tison
Vaccines 2024, 12(3), 339; https://doi.org/10.3390/vaccines12030339
Available online: https://www.mdpi.com/2076-393X/12/3/339